| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.004 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.14 | 0.006 |